Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian S Murphy

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Respiration; International Review of Thoracic Diseases|September 30, 2009
Pathogenesis of bronchopulmonary dysplasiaDon Hayes, David J Feola, Brian S Murphy, et al.
Journal of the International Association of Providers of AIDS Care|September 14, 2013
Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009Thein Myint, Majdi N Al-Hasan, Julie A Ribes, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2008
Azithromycin alters macrophage phenotypeBrian S Murphy, Vidya Sundareshan, Theodore J Cory, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Rhabdomyolysis during therapy with daptomycinStella Papadopoulos, Amanda M Ball, Susanne E Liewer, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|February 22, 2011
Pulmonary function outcomes in bronchopulmonary dysplasia through childhood and into adulthood: implications for primary careDon Hayes, J Thomas Meadows, Brian S Murphy, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2012
Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosaTheodore J Cory, Susan E Birket, Brian S Murphy, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with PseudomonasDavid J Feola, Beth A Garvy, Theodore J Cory, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2019
Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling PathwaysDalia Haydar, Theodore J Cory, Susan E Birket, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 24, 2010
Characterization of macrophage activation states in patients with cystic fibrosisBrian S Murphy, Heather M Bush, Vidya Sundareshan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 11, 2013
Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosisTheodore J Cory, Susan E Birket, Brian S Murphy, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Respiration; International Review of Thoracic Diseases|September 30, 2009
Pathogenesis of bronchopulmonary dysplasiaDon Hayes, David J Feola, Brian S Murphy, et al.
Journal of the International Association of Providers of AIDS Care|September 14, 2013
Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009Thein Myint, Majdi N Al-Hasan, Julie A Ribes, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2008
Azithromycin alters macrophage phenotypeBrian S Murphy, Vidya Sundareshan, Theodore J Cory, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Rhabdomyolysis during therapy with daptomycinStella Papadopoulos, Amanda M Ball, Susanne E Liewer, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|February 22, 2011
Pulmonary function outcomes in bronchopulmonary dysplasia through childhood and into adulthood: implications for primary careDon Hayes, J Thomas Meadows, Brian S Murphy, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2012
Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosaTheodore J Cory, Susan E Birket, Brian S Murphy, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with PseudomonasDavid J Feola, Beth A Garvy, Theodore J Cory, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2019
Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling PathwaysDalia Haydar, Theodore J Cory, Susan E Birket, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 24, 2010
Characterization of macrophage activation states in patients with cystic fibrosisBrian S Murphy, Heather M Bush, Vidya Sundareshan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 11, 2013
Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosisTheodore J Cory, Susan E Birket, Brian S Murphy, et al.
Pageof 3